Home » Stocks » MLSS

Milestone Scientific, Inc. (MLSS)

Stock Price: $3.92 USD -0.21 (-5.08%)
Updated Mar 3, 2021 4:00 PM EST - Market closed
After-hours: $3.90 -0.02 (-0.51%) Mar 3, 6:44 PM
Market Cap 261.97M
Revenue (ttm) 5.53M
Net Income (ttm) -9.12M
Shares Out 65.82M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 3
Last Price $3.92
Previous Close $4.13
Change ($) -0.21
Change (%) -5.08%
Day's Open 4.11
Day's Range 3.84 - 4.32
Day's Volume 779,983
52-Week Range 0.85 - 4.40

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Proactive Investors - 1 day ago

Milestone Scientific Inc (NYSEAMERICAN:MLSS), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, said Tuesday it has begun se...

GlobeNewsWire - 1 day ago

ROSELAND, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painles...

Proactive Investors - 1 week ago

Milestone Scientific Inc (NYSEAMERICAN:MLSS) announced Wednesday it had received a Notice of Allowance from the US patent office for its new CompuPulse System. The CompuPulse System integrates...

GlobeNewsWire - 1 week ago

CompuPulse integrates CompuWave™ technology with a manual syringe to verify needle and catheter placement CompuPulse integrates CompuWave™ technology with a manual syringe to verify needle and...

Proactive Investors - 1 week ago

Milestone Scientific Inc (NYSEAMERICAN:MLSS) said it has begun selling its CompuFloEpidural Instrument and related disposables to the University Hospital of Würzburg (UHW) in Germany. “We appr...

GlobeNewsWire - 1 week ago

ROSELAND, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless...

Proactive Investors - 2 weeks ago

Milestone Scientific Inc (NYSEAMERICAN:MLSS) reported that it has signed three additional distribution agreements in the US and one in Canada for the company's Wand Single Tooth Anesthesia (ST...

GlobeNewsWire - 2 weeks ago

Brings network to eight independent North American distributors in under one month Brings network to eight independent North American distributors in under one month

GlobeNewsWire - 2 weeks ago

ROSELAND, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, ann...

Proactive Investors - 3 weeks ago

Revolutionizing injections for doctors and patients CompuFlo instruments provide feedback to distinguish tissue types for precise location guidance Establishing relationships with world-class ...

Proactive Investors - 3 weeks ago

Milestone Scientific Inc (NYSEAMERICAN:MLSS) announced Tuesday that it has signed two additional distribution agreements with Atlanta Dental and Nashville Dental for its Wand Single Tooth Anes...

GlobeNewsWire - 3 weeks ago

Adds four independent U.S. distributors in under one month

GlobeNewsWire - 1 month ago

ROSELAND, N.J., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless...

GlobeNewsWire - 1 month ago

Agreements have been put into place with two distributors covering Florida, New York and New Jersey

GlobeNewsWire - 1 month ago

ROSELAND, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless...

GlobeNewsWire - 1 month ago

Milestone's FDA approved CompuFlo and CathCheck instruments and disposables provide significant safety and economic benefits Milestone's FDA approved CompuFlo and CathCheck instruments and dis...

GlobeNewsWire - 2 months ago

ROSELAND, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless...

Seeking Alpha - 3 months ago

MLSS's dental business has almost fully recovered from the pandemic lows, with several tailwinds on the horizon. MLSS progressed its medical side of the business significantly in early Q4 with...

GlobeNewsWire - 3 months ago

Anticipates over 40% sequential increase in sales for Q4 2020 versus Q3 2020 Anticipates over 40% sequential increase in sales for Q4 2020 versus Q3 2020

Seeking Alpha - 3 months ago

Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 3 months ago

ROSELAND, N.J., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise inject...

GlobeNewsWire - 4 months ago

ROSELAND, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise inject...

GlobeNewsWire - 4 months ago

Interview features advantages of the CompuFlo® Epidural System and CathCheck™ Interview features advantages of the CompuFlo® Epidural System and CathCheck™

GlobeNewsWire - 4 months ago

Agreement provides Premier’s 4,100 hospitals and 200,000 provider members with preferred access to CompuFlo® Epidural System and CathCheck™ Agreement provides Premier’s 4,100 hospitals and 200...

Seeking Alpha - 4 months ago

MLSS has been hit hard by COVID-19, but their dental business has shown strong signs of recovery.

GlobeNewsWire - 5 months ago

ROSELAND, N.J., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides painless and prec...

Seeking Alpha - 6 months ago

Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q2 2020 Results - Earnings Call Transcript

Seeking Alpha - 9 months ago

Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 10 months ago

Milestone Scientific Surges Again

Seeking Alpha - 1 year ago

High-Risk, High-Reward Investors Should Love Milestone Scientific

Seeking Alpha - 1 year ago

Milestone Scientific Inc. (MLSS) Q3 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

The company is using its profitable business for dental practices as a cash cow to develop its medical business.

Seeking Alpha - 1 year ago

Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Milestone Scientific Inc. (MLSS) CEO Len Osser on Q1 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Milestone Scientific Inc. (MLSS) on Q4 2018 Results - Earnings Call Transcript

About MLSS

Milestone Scientific develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns. The company also offers CompuFlo, a computer-controlled drug delivery system for th... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Nov 3, 1995
CEO
Leonard A. Osser
Employees
16
Stock Exchange
NYSEAMERICAN
Ticker Symbol
MLSS
Full Company Profile

Financial Performance

In 2019, MLSS's revenue was $8.37 million, a decrease of -12.97% compared to the previous year's $9.62 million. Losses were -$7.52 million, 1.25% more than in 2018.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for MLSS stock is "Buy" and the 12-month stock price forecast is 7.00.

Price Target
$7.00
Analyst Consensus: Buy